Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381617177> ?p ?o ?g. }
- W4381617177 endingPage "3279" @default.
- W4381617177 startingPage "3279" @default.
- W4381617177 abstract "B7-H3 is a 4Ig transmembrane protein that emerged as a tumor-associated antigen in neuroblastoma. It belongs to the B7 family, shows an immunoregulatory role toward NK and T cells, and, therefore, has been included in the growing family of immune checkpoints. Besides neuroblastoma, B7-H3 is expressed by many pediatric cancers including tumors of the central nervous system, sarcomas, and acute myeloid leukemia. In children, particularly those affected by solid tumors, the therapeutic protocols are aggressive and cause important life-threatening side effects. Moreover, despite the improved survival observed in the last decade, a relevant number of patients show therapy resistance and fatal relapses. Immunotherapy represents a new frontier in the cure of cancer patients and the targeting of tumor antigens or immune checkpoints blockade showed exciting results in adults. In this encouraging scenario, researchers and clinicians are exploring the possibility to use immunotherapeutics targeting B7-H3; these include mAbs and chimeric antigen receptor T-cells (CAR-T). These tools are rapidly evolving to improve the efficacy and decrease the unwanted side effects; drug-conjugated mAbs, bi-tri-specific mAbs or CAR-T, and, very recently, NK cell engagers (NKCE), tetra-specific molecules engaging a tumor-associated antigen and NK cells, have been generated. Preclinical data are promising, and clinical trials are ongoing. Hopefully, the B7-H3 targeting will provide important benefits to cancer patients." @default.
- W4381617177 created "2023-06-23" @default.
- W4381617177 creator A5012409208 @default.
- W4381617177 creator A5048640766 @default.
- W4381617177 creator A5070179281 @default.
- W4381617177 creator A5071490003 @default.
- W4381617177 date "2023-06-21" @default.
- W4381617177 modified "2023-10-14" @default.
- W4381617177 title "B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma" @default.
- W4381617177 cites W1506819618 @default.
- W4381617177 cites W1543362153 @default.
- W4381617177 cites W1553363554 @default.
- W4381617177 cites W1652018515 @default.
- W4381617177 cites W2005055996 @default.
- W4381617177 cites W2007987850 @default.
- W4381617177 cites W2011182234 @default.
- W4381617177 cites W2034389512 @default.
- W4381617177 cites W2039721940 @default.
- W4381617177 cites W2048472253 @default.
- W4381617177 cites W2052644931 @default.
- W4381617177 cites W2062840276 @default.
- W4381617177 cites W2081513802 @default.
- W4381617177 cites W2106306465 @default.
- W4381617177 cites W2110172571 @default.
- W4381617177 cites W2121934915 @default.
- W4381617177 cites W2149312162 @default.
- W4381617177 cites W2150648275 @default.
- W4381617177 cites W2152714839 @default.
- W4381617177 cites W2155823461 @default.
- W4381617177 cites W2419140434 @default.
- W4381617177 cites W2524515200 @default.
- W4381617177 cites W2531805832 @default.
- W4381617177 cites W2591937746 @default.
- W4381617177 cites W2737148036 @default.
- W4381617177 cites W2801777436 @default.
- W4381617177 cites W2910164268 @default.
- W4381617177 cites W2923249203 @default.
- W4381617177 cites W2924812697 @default.
- W4381617177 cites W2944887118 @default.
- W4381617177 cites W2945412645 @default.
- W4381617177 cites W2970981785 @default.
- W4381617177 cites W2996412194 @default.
- W4381617177 cites W2997191670 @default.
- W4381617177 cites W3008063258 @default.
- W4381617177 cites W3087276994 @default.
- W4381617177 cites W3089727781 @default.
- W4381617177 cites W3115103236 @default.
- W4381617177 cites W3121900820 @default.
- W4381617177 cites W3124707330 @default.
- W4381617177 cites W3128868608 @default.
- W4381617177 cites W3129393016 @default.
- W4381617177 cites W3135689743 @default.
- W4381617177 cites W3140310152 @default.
- W4381617177 cites W3160165747 @default.
- W4381617177 cites W3174246647 @default.
- W4381617177 cites W3185708072 @default.
- W4381617177 cites W3195784738 @default.
- W4381617177 cites W3197506186 @default.
- W4381617177 cites W3199964030 @default.
- W4381617177 cites W3203925015 @default.
- W4381617177 cites W4205551017 @default.
- W4381617177 cites W4214933333 @default.
- W4381617177 cites W4224261339 @default.
- W4381617177 cites W4283452973 @default.
- W4381617177 cites W4285794953 @default.
- W4381617177 cites W4287218449 @default.
- W4381617177 cites W4288060409 @default.
- W4381617177 cites W4306746466 @default.
- W4381617177 cites W4306795470 @default.
- W4381617177 cites W4306909286 @default.
- W4381617177 cites W4307689418 @default.
- W4381617177 cites W4308449920 @default.
- W4381617177 cites W4313472141 @default.
- W4381617177 cites W4319985555 @default.
- W4381617177 cites W4322502511 @default.
- W4381617177 cites W4322753317 @default.
- W4381617177 cites W4324056667 @default.
- W4381617177 cites W4328112927 @default.
- W4381617177 cites W4364374660 @default.
- W4381617177 cites W4367057127 @default.
- W4381617177 doi "https://doi.org/10.3390/cancers15133279" @default.
- W4381617177 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37444389" @default.
- W4381617177 hasPublicationYear "2023" @default.
- W4381617177 type Work @default.
- W4381617177 citedByCount "0" @default.
- W4381617177 crossrefType "journal-article" @default.
- W4381617177 hasAuthorship W4381617177A5012409208 @default.
- W4381617177 hasAuthorship W4381617177A5048640766 @default.
- W4381617177 hasAuthorship W4381617177A5070179281 @default.
- W4381617177 hasAuthorship W4381617177A5071490003 @default.
- W4381617177 hasBestOaLocation W43816171771 @default.
- W4381617177 hasConcept C121608353 @default.
- W4381617177 hasConcept C126322002 @default.
- W4381617177 hasConcept C143998085 @default.
- W4381617177 hasConcept C147483822 @default.
- W4381617177 hasConcept C170493617 @default.
- W4381617177 hasConcept C203014093 @default.
- W4381617177 hasConcept C2776715637 @default.